Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Feline Panleukopenia Virus Tyrosine-Protein Kinase Transforming Protein Fgr (V-FGR)

Cat. No.VG2C161

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Feline Panleukopenia Virus Tyrosine-Protein Kinase Transforming Protein Fgr (V-FGR) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 61.5 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 61.5 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 5%-50% glycerol

Target Information

In veterinary medicine, feline panleukopenia virus tyrosine-protein kinase transforming protein Fgr (V-FGR) is used to study viral pathogenesis and host interactions. As a member of the Src family of tyrosine kinases, V-FGR is involved in viral infection processes and may influence virulence and host range. Research on V-FGR also aids in the development of specific antiviral therapies and vaccines for feline panleukopenia.

Protein Feline Panleukopenia Virus Tyrosine-Protein Kinase Transforming Protein Fgr (V-FGR)
Protein Synonym V-FGR; SRC-2; Tyrosine-protein kinase transforming protein Fgr
UniProt ID P00544

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket